Dr. Robertson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1030 W Michigan St
Indianapolis, IN 46202Phone+1 317-944-0920Fax+1 317-944-3684- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1987 - 1990
- University of ChicagoResidency, Internal Medicine, 1984 - 1987
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1984
Certifications & Licensure
- IN State Medical License 1996 - 2025
- IL State Medical License 1984 - 2003
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Start of enrollment: 1997 Oct 01
- Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
Publications & Presentations
PubMed
- 8 citationsPost-transplant lymphoproliferative disorder: Update on treatment and novel therapies.Suheil Albert Atallah-Yunes, Omar Salman, Michael J Robertson> ;British Journal of Haematology. 2023 May 1
- 2 citationsEpigenetic Aberrations and Targets in Peripheral T-Cell Lymphoma.Suheil Albert Atallah-Yunes, Michael J Robertson, Utpal P Davé> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Sep 1
- 1 citationsCurrent and emerging monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies in treatment of lymphoma.Suheil Albert Atallah-Yunes, Michael J Robertson> ;Leukemia Research Reports. 2022 Jan 1
- Join now to see all
Grant Support
- Mechanisms Of STAT4 Deficiency In The Immune System Of Cancer PatientsNational Cancer Institute2007–2011
- Recombinant Human Interleukin-18 For Treatment Of A Patient With MetastaticNational Center For Research Resources2005
- Rhu IL 12 After High Dose &Autologous Hematopoietic Stem CellsNational Center For Research Resources1999–2002
Professional Memberships
- Member
Hospital Affiliations
- Eskenazi HealthIndianapolis, Indiana
- Indiana University Health University HospitalIndianapolis, Indiana
- Richard L. Roudebush Veterans Affairs Medical CenterIndianapolis, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: